tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ARTV Stock Latest News

Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
Stock Analysis & IdeasWedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
2M ago
ARTV
BCRX
Artiva Biotherapeutics Executes RSU Exchange for Employees
PremiumCompany Announcements
Artiva Biotherapeutics Executes RSU Exchange for Employees
2M ago
8K
ARTV
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development
PremiumCompany Announcements
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development
3M ago
ARTV
Promising Developments in Artiva Biotherapeutics’ AlloNK Therapy for Autoimmune Diseases
PremiumRatings
Promising Developments in Artiva Biotherapeutics’ AlloNK Therapy for Autoimmune Diseases
3M ago
ARTV
Buy Rating for Artiva Biotherapeutics, Inc. Based on Promising Clinical Results and Competitive Edge
PremiumRatings
Buy Rating for Artiva Biotherapeutics, Inc. Based on Promising Clinical Results and Competitive Edge
3M ago
ARTV
Buy Rating for Artiva Biotherapeutics Based on Promising AlloNK Combination Therapy Results
PremiumRatingsBuy Rating for Artiva Biotherapeutics Based on Promising AlloNK Combination Therapy Results
3M ago
ARTV
Artiva Biotherapeutics Reports Positive AlloNK Trial Results
Premium
Company Announcements
Artiva Biotherapeutics Reports Positive AlloNK Trial Results
3M ago
8K
ARTV
Artiva Biotherapeutics announces safety, translational data from AlloNK
Premium
The Fly
Artiva Biotherapeutics announces safety, translational data from AlloNK
3M ago
ARTV
Artiva Biotherapeutics reports Q3 EPS (88c) vs (92c) last year
PremiumThe Fly
Artiva Biotherapeutics reports Q3 EPS (88c) vs (92c) last year
3M ago
ARTV
Artiva Biotherapeutics Advances with Promising NK Cell Therapy Study
PremiumCompany Announcements
Artiva Biotherapeutics Advances with Promising NK Cell Therapy Study
3M ago
ARTV
Artiva Biotherapeutics Advances Lupus Treatment with Innovative NK-Cell Therapy
PremiumCompany Announcements
Artiva Biotherapeutics Advances Lupus Treatment with Innovative NK-Cell Therapy
3M ago
ARTV
Artiva Biotherapeutics Advances in Cancer Therapy with GCC2005 Study Update
PremiumCompany Announcements
Artiva Biotherapeutics Advances in Cancer Therapy with GCC2005 Study Update
3M ago
ARTV
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up: Friday’s Biggest Stock Market Stories!
4M ago
BP
MU
Why Is Artiva Biotherapeutics Stock (ARTV) Up 105% Today?
Premium
Market News
Why Is Artiva Biotherapeutics Stock (ARTV) Up 105% Today?
4M ago
ARTV
Morning Movers: Regional banks in focus after reporting Q3 results
Premium
The Fly
Morning Movers: Regional banks in focus after reporting Q3 results
4M ago
MU
AXP
Artiva Biotherapeutics price target raised to $23 from $18 at Wedbush
PremiumThe Fly
Artiva Biotherapeutics price target raised to $23 from $18 at Wedbush
4M ago
ARTV
Promising Developments and Strategic Advancements at Artiva Biotherapeutics Drive Buy Rating
PremiumRatings
Promising Developments and Strategic Advancements at Artiva Biotherapeutics Drive Buy Rating
4M ago
ARTV
Artiva Biotherapeutics: Strategic Positioning in Rheumatoid Arthritis Market with Promising AlloNK Therapy
PremiumRatings
Artiva Biotherapeutics: Strategic Positioning in Rheumatoid Arthritis Market with Promising AlloNK Therapy
4M ago
ARTV
Artiva Biotherapeutics Reports Progress in Clinical Trials
PremiumCompany Announcements
Artiva Biotherapeutics Reports Progress in Clinical Trials
5M ago
ARTV
Positive Buy Rating for Artiva Biotherapeutics, Inc. Driven by Promising AlloNK Cell Therapy Developments
PremiumRatingsPositive Buy Rating for Artiva Biotherapeutics, Inc. Driven by Promising AlloNK Cell Therapy Developments
6M ago
ARTV
Buy Rating Affirmed for Artiva Biotherapeutics Amid Promising AlloNK Data and Strong Financial Position
Premium
Ratings
Buy Rating Affirmed for Artiva Biotherapeutics Amid Promising AlloNK Data and Strong Financial Position
6M ago
ARTV
Artiva Biotherapeutics files $300M mixed securities shelf
Premium
The Fly
Artiva Biotherapeutics files $300M mixed securities shelf
6M ago
ARTV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >